The biotech scene can be seen as fairly risky for new investors who want to put money to work. After all, it's really tough to gauge which innovative biotech firms will have something genuinely ground ...
It's a general rule of thumb that you should compare your portfolio to the returns of the S&P 500 benchmark index. The ...